In this study we report that the transcription factor EBF1 is down-regulated in CRC tissues of patients with poorer outcomes and that EBF1 over-expression suppresses tumor growth in vivo and in vitro by inhibiting proliferation and inducing apoptosis. This evidence concerns the gene EBF1 and neoplasm.